Nano123 : Preissteigerung
Aktuell von der Website vom 31.03. 6am EDT:
"(...) today that the U.S. Food and Drug Administration (FDA) just provided clearance for initiation of a Phase 2 trial with CytoDyn?s leronlimab to treat COVID-19 patients with mild to moderate indications. The Company?s investigational new drug, leronlimab, has been administered to 10 severely ill patients with COVID-19 at a leading medical center in the New York City area under an emergency IND recently granted by the FDA. "